SOT | DVA | POMA | DGI | VAS | HADS | DHI | ABC | TUG | |||
---|---|---|---|---|---|---|---|---|---|---|---|
R | L | ||||||||||
Case1 | pre | 54 | 0.14 | 0.3 | 21 | 16 | 4 | 29 | 52 | 6.19 | 7.2 |
female | post | 77 | 0.02 | 0.2 | 24 | 18 | 1 | 6 | 14 | 9.25 | 6.5 |
62 y/o | Follow-up | 67 | 0.016 | 0.016 | 23 | 20 | 1 | 8 | 10 | 9.31 | 6.78 |
Case2 | pre | 53 | 0.48 | 0.5 | 15 | 13 | 5-7 | 32 | 54 | 4.44 | 12.58 |
female | post | 70 | 0.32 | 0.28 | 24 | 17 | 3 | 12 | 24 | 6.81 | 10.58 |
78 y/o | Follow-up | 71 | 0.12 | 0.22 | 24 | 19 | 2 | 19 | 12 | 7.38 | 10.32 |
Case3 | pre | 56 | 0.2 | 0.7 | 23 | 13 | 4 | 23 | 66 | 6.31 | 13.85 |
male | post | 83 | 0.06 | 0.26 | 27 | 19 | 1 | 17 | 36 | 9.12 | 11.42 |
67 y/o | Follow-up | 80 | 0.10 | 0.18 | 25 | 18 | 1 | 16 | 24 | 9.31 | 10.9 |
Case4 | pre | 81 | 0.5 | 0.6 | 25 | 18 | 5 | 26 | 50 | 9.5 | 9.5 |
female | post | 83 | 0.1 | 0 | 28 | 23 | 1 | 16 | 24 | 9.69 | 8.23 |
40 y/o | Follow-up | 78 | 0.22 | 0.22 | 28 | 22 | 2 | 18 | 28 | 9.6 | 7.96 |